DreaMed Diabetes, developer of diabetes management solutions, announced today that it received CE Mark for the Advisor Pro decision-support platform for assisting healthcare professionals in the management of Type 1 diabetes.
Read more on Cardiovascular Business here.
![[ReWalk in GlobeNewswire] ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
